These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 26162363)

  • 1. Comparing multidrug-resistant tuberculosis patient costs under molecular diagnostic algorithms in South Africa.
    du Toit E; Squire SB; Dunbar R; Machekano R; Madan J; Beyers N; Naidoo P
    Int J Tuberc Lung Dis; 2015 Aug; 19(8):960-8. PubMed ID: 26162363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathways to multidrug-resistant tuberculosis diagnosis and treatment initiation: a qualitative comparison of patients' experiences in the era of rapid molecular diagnostic tests.
    Naidoo P; van Niekerk M; du Toit E; Beyers N; Leon N
    BMC Health Serv Res; 2015 Oct; 15():488. PubMed ID: 26511931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of multidrug-resistant tuberculosis treatment commencement times in MDRTBPlus line probe assay and Xpert® MTB/RIF-based algorithms in a routine operational setting in Cape Town.
    Naidoo P; du Toit E; Dunbar R; Lombard C; Caldwell J; Detjen A; Squire SB; Enarson DA; Beyers N
    PLoS One; 2014; 9(7):e103328. PubMed ID: 25079599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing laboratory costs of smear/culture and Xpert
    Naidoo P; Dunbar R; du Toit E; van Niekerk M; Squire SB; Beyers N; Madan J
    Int J Tuberc Lung Dis; 2016 Oct; 20(10):1377-1385. PubMed ID: 27725051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosing Xpert MTB/RIF negative TB: impact and cost of alternative algorithms for South Africa.
    Schnippel K; Meyer-Rath G; Long L; Stevens WS; Sanne I; Rosen S
    S Afr Med J; 2013 Jan; 103(2):101-6. PubMed ID: 23374320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs of inpatient treatment for multi-drug-resistant tuberculosis in South Africa.
    Schnippel K; Rosen S; Shearer K; Martinson N; Long L; Sanne I; Variava E
    Trop Med Int Health; 2013 Jan; 18(1):109-16. PubMed ID: 23170876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost minimization analysis of line probe assay for detection of multidrug-resistant tuberculosis in Arkhangelsk region of Russian Federation.
    Bogdanova EN; Mariandyshev AO; Balantcev GA; Eliseev PI; Nikishova EI; Gaida AI; Enarson D; Detjen A; Dacombe R; Phillips PPJ; Squire SB; Gospodarevskaya E
    PLoS One; 2019; 14(1):e0211203. PubMed ID: 30695043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review.
    Laurence YV; Griffiths UK; Vassall A
    Pharmacoeconomics; 2015 Sep; 33(9):939-55. PubMed ID: 25939501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient and family costs associated with tuberculosis, including multidrug-resistant tuberculosis, in Ecuador.
    Rouzier VA; Oxlade O; Verduga R; Gresely L; Menzies D
    Int J Tuberc Lung Dis; 2010 Oct; 14(10):1316-22. PubMed ID: 20843424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial.
    Theron G; Zijenah L; Chanda D; Clowes P; Rachow A; Lesosky M; Bara W; Mungofa S; Pai M; Hoelscher M; Dowdy D; Pym A; Mwaba P; Mason P; Peter J; Dheda K;
    Lancet; 2014 Feb; 383(9915):424-35. PubMed ID: 24176144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost of multi drug resistance tuberculosis in Germany.
    Diel R; Nienhaus A; Lampenius N; Rüsch-Gerdes S; Richter E
    Respir Med; 2014 Nov; 108(11):1677-87. PubMed ID: 25443398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of replacing smear microscopy with Xpert MTB/RIF for diagnosing tuberculosis in Brazil: a stepped-wedge cluster-randomized trial.
    Durovni B; Saraceni V; van den Hof S; Trajman A; Cordeiro-Santos M; Cavalcante S; Menezes A; Cobelens F
    PLoS Med; 2014 Dec; 11(12):e1001766. PubMed ID: 25490549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stepwise implementation of a new diagnostic algorithm for multidrug-resistant tuberculosis in Haiti.
    Gauthier M; Somoskövi A; Berland JL; Ocheretina O; Mabou MM; Boncy J; Gutierrez C; Vernet G; Pape JW
    Int J Tuberc Lung Dis; 2014 Feb; 18(2):220-6. PubMed ID: 24429317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient costs for the diagnosis of tuberculosis in Brazil: comparison of Xpert MTB/RIF and smear microscopy.
    da Silva Antunes R; Pinto M; Trajman A
    Int J Tuberc Lung Dis; 2014 May; 18(5):547-51. PubMed ID: 24903791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis.
    Pantoja A; Fitzpatrick C; Vassall A; Weyer K; Floyd K
    Eur Respir J; 2013 Sep; 42(3):708-20. PubMed ID: 23258774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Xpert MTB/RIF assay at a tertiary care referral hospital in a setting where tuberculosis and HIV infection are highly endemic.
    O'Grady J; Bates M; Chilukutu L; Mzyece J; Cheelo B; Chilufya M; Mukonda L; Mumba M; Tembo J; Chomba M; Kapata N; Maeurer M; Rachow A; Clowes P; Hoelscher M; Mwaba P; Zumla A
    Clin Infect Dis; 2012 Nov; 55(9):1171-8. PubMed ID: 22806590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introducing new tuberculosis diagnostics: the impact of Xpert(®) MTB/RIF testing on case notifications in Nepal.
    Creswell J; Rai B; Wali R; Sudrungrot S; Adhikari LM; Pant R; Pyakurel S; Uranw D; Codlin AJ
    Int J Tuberc Lung Dis; 2015 May; 19(5):545-51. PubMed ID: 25868022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-optimization in the treatment of multidrug resistant tuberculosis in Nigeria.
    Musa BM; John D; Habib AG; Kuznik A
    Trop Med Int Health; 2016 Feb; 21(2):176-82. PubMed ID: 26610176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of the INNO-LiPA Rif. TB® line-probe assay in rapid detection of multidrug-resistant tuberculosis in Latvia.
    Skenders GK; Holtz TH; Riekstina V; Leimane V
    Int J Tuberc Lung Dis; 2011 Nov; 15(11):1546-52, i. PubMed ID: 22008771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients' costs associated with seeking and accessing treatment for drug-resistant tuberculosis in South Africa.
    Ramma L; Cox H; Wilkinson L; Foster N; Cunnama L; Vassall A; Sinanovic E
    Int J Tuberc Lung Dis; 2015 Dec; 19(12):1513-9. PubMed ID: 26614194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.